SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-034238
Filing Date
2024-03-14
Accepted
2024-03-14 07:44:21
Documents
4
Period of Report
2024-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2328688d2_6k.htm 6-K 10693
2 EXHIBIT 99.1 tm2328688d2_ex99-1.htm EX-99.1 128554
3 EXHIBIT 99.2 tm2328688d2_ex99-2.pdf EX-99.2 3324795
4 GRAPHIC tm2328688d2_ex99-1img001.jpg GRAPHIC 7899
  Complete submission text file 0001104659-24-034238.txt   4720135
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 24747947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)